...Evaluate the Effects of ASA404 Alone and in Combination with Taxane-Based Chemotherapy on the Pharmacokinetics...Simvastin, Caffeine, Omeprazole..

Printer-friendly versionSend by emailPDF version

Name

Novartis Pharmaceutical Corporation

Anticipated Amount

10 625.00

Activity Type

Clinical Trial

Award Type

Contract

Date

August 7, 2010 to August 30, 2010

Award Number

003760-00001

Sponsor Award Number

CASA404A-2111

Award Contacts

Name

Stopeck,Alison T

Title

Principal Investigator

Unit

Medicine

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona